Back to Search
Start Over
Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
- Source :
- European Urology Oncology; February 2020, Vol. 3 Issue: 1 p119-127, 9p
- Publication Year :
- 2020
-
Abstract
- It is hypothesised that cotargeting the androgen receptor (AR) and paracrine androgen biosynthesis with enzalutamide and abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC) will dissipate adaptive feedback loops observed with either agent alone.
Details
- Language :
- English
- ISSN :
- 25889311
- Volume :
- 3
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- European Urology Oncology
- Publication Type :
- Periodical
- Accession number :
- ejs52327714
- Full Text :
- https://doi.org/10.1016/j.euo.2019.01.008